NASDAQ:ADUS - Addus Homecare Stock Price, Forecast & News

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Addus Homecare Co. (NASDAQ:ADUS) announced its earnings results on Monday, November, 4th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.49 by $0.13. The company earned $169.80 million during the quarter, compared to analysts' expectations of $160.25 million. Addus Homecare had a net margin of 3.35% and a return on equity of 8.00%. The firm's revenue was up 23.3% on a year-over-year basis. View Addus Homecare's Earnings History.

Addus Homecare is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Addus Homecare.

Addus Homecare will be holding an earnings conference call on Thursday, February 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

7 analysts have issued twelve-month price objectives for Addus Homecare's stock. Their forecasts range from $85.00 to $115.00. On average, they expect Addus Homecare's stock price to reach $99.83 in the next twelve months. This suggests a possible upside of 3.6% from the stock's current price. View Analyst Price Targets for Addus Homecare.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Addus Homecare.

News headlines about ADUS stock have been trending neutral this week, InfoTrie reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Addus Homecare earned a news impact score of 0.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Addus Homecare.

Some companies that are related to Addus Homecare include BioScrip (BIOS), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), Option Care Health (OPCH) and New York Health Care (BBAL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include AbbVie (ABBV), Incyte (INCY), Bristol-Myers Squibb (BMY), Humana (HUM), Verizon Communications (VZ), Align Technology (ALGN), Activision Blizzard (ATVI), Cisco Systems (CSCO), Gilead Sciences (GILD) and Ulta Beauty (ULTA).

Addus Homecare's stock is owned by a number of of retail and institutional investors. Top institutional investors include Eos Management L.P. (6.69%), Principal Financial Group Inc. (2.63%), Standard Life Aberdeen plc (2.46%), State Street Corp (2.41%), Capital World Investors (1.86%) and Eaton Vance Management (1.56%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Institutional Ownership Trends for Addus Homecare.

ADUS stock was sold by a variety of institutional investors in the last quarter, including Eos Management L.P., Point72 Asset Management L.P., Marshall Wace LLP, Royce & Associates LP, Castleark Management LLC, FMR LLC, PNC Financial Services Group Inc. and Chartwell Investment Partners LLC. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Susan T Weaver and W Bradley Bickham. View Insider Buying and Selling for Addus Homecare.

ADUS stock was bought by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, Redwood Investments LLC, Fort Washington Investment Advisors Inc. OH, Rothschild & Co. Asset Management US Inc., Marshall Wace North America L.P., Capital World Investors, First Trust Advisors LP and State Street Corp. View Insider Buying and Selling for Addus Homecare.

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ADUS stock can currently be purchased for approximately $96.40.

Addus Homecare has a market capitalization of $1.50 billion and generates $518.12 million in revenue each year. The company earns $17.50 million in net income (profit) each year or $1.69 on an earnings per share basis. Addus Homecare employs 33,153 workers across the globe.View Additional Information About Addus Homecare.

The official website for Addus Homecare is http://www.addus.com/.

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]